Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy.
Treatment of neurological injury with thymosin β4.
Tobacco Smoke-Induced Brain White Matter Myelin Dysfunction: Potential Co-Factor Role of Smoking in Neurodegeneration.
A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.
Glatiramer acetate (Copaxone) induces degenerate, Th2-polarized immune responses in patients with multiple sclerosis.
Pericytes are required for blood-brain barrier integrity during embryogenesis.
Biogen Idec submits application to FDA for approval of PLEGRIDY™ (peginterferon beta-1a) in multiple sclerosis
[Experience of using genfaxon for treating patients with relapsing-remitting multiple sclerosis in the Russian Federation.]
Immunosuppressive properties of mesenchymal stem cells: advances and applications.
The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
Neuroprotection with glatiramer acetate: evidence from the PreCISe trial.
Raxone®/Catena® (idebenone)
Thrombotic microangiopathy associated with use of interferon-beta.
Integrated genomic and prospective clinical studies show the importance of modular pleiotropy for disease susceptibility, diagnosis and treatment.
The potential teratogenic effects of interferon beta-1a (IFNβ-1a) and interferon beta-1b (IFNβ-1b) on in vitro embryonic development.
Evaluation of pattern-reversal visual evoked potential in patients with neuromyelitis optica.
Gastrointestinal Tolerability of Delayed-Release Dimethyl Fumarate in a Multicenter, Open-Label Study of Patients with Relapsing Forms of Multiple Sclerosis (MANAGE).
Novel MS Drug Offers Good Functional Outcomes
New Drugs Online report for idebenone
Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis.
Comparative pharmacokinetics and pharmacodynamics of recombinant human interferon beta-1a after intramuscular and subcutaneous administration.
Altered serum content of brain-derived neurotrophic factor isoforms in multiple sclerosis.
UCSF Seminar: "Dynamics of Retina Damage in Acute Optic Neuritis"
Complex antibody profiling to predict clinical outcome in childhood ADS.
Development of interferon beta-neutralising antibodies in multiple sclerosis-a systematic review and meta-analysis.

Pages